Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Wockhardt Denies Stake-Sale Speculation, Stock Pares Its Gains

July 25 (Bloomberg) -- Wockhardt Ltd. pared gains of as much as 18 percent today after the Indian generic drugmaker said it doesn’t plan to sell a stake.

The stock rose 14 percent to 749.35 rupees at the close in Mumbai, still the most since April 2. The initial gains were triggered by speculation of a stake sale, said Arun Kejriwal, director at Kejriwal Research & Investment in Mumbai.

“There’s no question of selling stake,” Dominic D’Souza, a spokesman for Wockhardt, said in a phone interview today. “We strongly deny the rumor.”

Global companies invested about 280 billion rupees ($4.66 billion) in Indian drugmakers in the three years through 2013 to gain greater control over factories that supply the lucrative U.S. market, data from the Ministry of Commerce show. The S&P BSE Healthcare Index has tripled in value in the past five years, outpacing the 62 percent gain in the benchmark S&P BSE Sensex.

Shares of Mumbai-based have jumped 66 percent this year, faster than the 23 percent climb in the Sensex. The stock’s 10-day volatility rose to 56.5, the highest since June 9, amid volume that was 9.6 times the daily three-month average, the data show.

“We are advising investors to avoid the stock for now as there’s too much volatility,” said Kejriwal.

To contact the reporter on this story: Santanu Chakraborty in Mumbai at schakrabor11@bloomberg.net

To contact the editors responsible for this story: Michael Patterson at mpatterson10@bloomberg.net; Anjali Cordeiro at acordeiro2@bloomberg.net Ravil Shirodkar, Dick Schumacher

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.